Literature DB >> 3694257

Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin.

J N Larocca1, R W Ledeen, B Dvorkin, M H Makman.   

Abstract

High-affinity muscarinic cholinergic receptors were detected in myelin purified from rat brain stem with use of the radioligands 3H-N-methylscopolamine (3H-NMS), 3H-quinuclidinyl benzilate (3H-QNB), and 3H-pirenzepine. 3H-NMS binding was also present in myelin isolated from corpus callosum. In contrast, several other receptor types, including alpha 1- and alpha 2-adrenergic receptors, present in the starting brain stem, were not detected in myelin. Based on Bmax values from Scatchard analyses, 3H-pirenzepine, a putative M1 selective ligand, bound to about 25% of the sites in myelin labeled by 3H-NMS, a nonselective ligand that binds to both M1 and M2 receptor subtypes. Agonist affinity for 3H-NMS binding sites in myelin was markedly decreased by Gpp(NH)p, indicating that a major portion of these receptors may be linked to a second messenger system via a guanine-nucleotide regulatory protein. Purified myelin also contained adenylate cyclase activity; this activity was stimulated several fold by forskolin and to small but significant extents by prostaglandin E1 and the beta-adrenergic agonist isoproterenol. Myelin adenylate cyclase activity was inhibited by carbachol and other muscarinic agonists; this inhibition was blocked by the antagonist atropine. Levels in myelin of muscarinic receptors were 20-25% and those of forskolin-stimulated adenylate cyclase 10% of the values for total particulate fraction of whole brain stem. These levels in myelin are appreciably greater than would be predicted on the basis of contamination. Also, additional receptors and adenylate cyclase, added by mixing nonmyelin tissue with whole brain stem, were quantitatively removed during the purification procedure. In conclusion, both M1 and M2 muscarinic receptor subtypes and an adenylate cyclase system linked to at least some of these receptors are present as intrinsic components of myelin. The possibility that some of these muscarinic receptors may be involved in regulation of phosphinositide metabolism and the protein kinase activities of myelin is considered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694257      PMCID: PMC6569090     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

Review 1.  Myelin biogenesis: vesicle transport in oligodendrocytes.

Authors:  J N Larocca; A G Rodriguez-Gabin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 2.  Phosphorylation of myelin protein: recent advances.

Authors:  J Eichberg; S Iyer
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

3.  Characterization of guanylyl cyclase in purified myelin.

Authors:  M Grabow; G Chakraborty; R W Ledeen
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 4.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

5.  ADP-ribosyltransferase activity in myelin membranes isolated from human brain.

Authors:  C Boulias; F G Mastronardi; M A Moscarello
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 6.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

7.  The cyclic AMP-dependent protein kinase catalytic subunit selectively enhances calcium currents in rat nodose neurones.

Authors:  R A Gross; M D Uhler; R L Macdonald
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

8.  The phosphoinositide signaling cycle in myelin requires cooperative interaction with the axon.

Authors:  G Chakraborty; A Drivas; R Ledeen
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 9.  Axon-myelin transfer of phospholipids and phospholipid precursors. Labeling of myelin phosphoinositides through axonal transport.

Authors:  R W Ledeen; F Golly; J E Haley
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

10.  Selective attenuation of Ether-a-go-go related K+ currents by endogenous acetylcholine reduces spike-frequency adaptation and network correlation.

Authors:  Edward D Cui; Ben W Strowbridge
Journal:  Elife       Date:  2019-04-29       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.